账号:    
密码:    
验证码:     看不清?点击更换 
    

药物临床试验网--国内大型的临床试验社区门户,专注临床试验,临床研究,CRO、CRA、SMO、CRC信息传播、技术交流、教育培训和专业技术人才服务

当前位置: 首页 > 业内资讯 >

Top 5 strategic deals in 2011

2011年12月26日来自:Outsourcing-pharma.com 作者: 点击:
我要操作

It seems partnerships have made headlines almost every day in 2011, with more companies joining forces to align their expertise. Here’s the stories you wanted to see…

 

Takeda enters into partnership with Quintiles and Covance

Takeda caught your attention in February when it thrashed out strategic development alliances with Covance and Quintiles. The agreements were part of what Takeda said was its ‘global program-level sourcing strategy´.

UBC looking to 'buy or build' to serve strategic partnerships

More recently, UBC announced it was looking to expand in a bid to attract more partnerships. The firm’s new president Rob Epstein told Outsourcing-Pharma it has been approached by clients similar to its star players Sanofi and Pfizer.

DSM seeks CMO partner to diversify beyond big pharma

Tired of relying on its big pharma clients to resuscitate its flagging business unit, in April DSM announced it was looking for a partner for it CMO business. Last week they finalised a deal with AIBN.

Quintiles says new financing-partnership approach could replace 'old fashioned' outsourcing models

Quintiles made the headlines just last week with its deal with Intarcia, which it claimed could change the way the industry thinks about outsourcing. Under the alliance, Quintiles will provide both finance and researchers to work on Intarcia's new Duros Type 2 diabetes tech.

ACRO, Quintiles, PRA and Theorem talk strategic partnering at DIA 2011

(责任编辑:DRUGGCP.NET)
2
------分隔线----------------------------
发表评论
请自觉遵守互联网相关的政策法规,严禁发布色情、暴力、反动的言论。
评价:
用户名: 验证码: 点击我更换图片
发布者资料
lance 查看详细资料 发送留言 加为好友 用户等级:高级会员 注册时间:1970-01-01 08:01 最后登录:2015-10-01 14:10
友情链接

广告业务| 关于我们| 联系我们| 免责声明| 服务条款| 使用帮助| 返回顶部